Home

  • Home
    • » e-Newsletters

Rechargeable neurostimulators receive HCPCS codes

Ambulatory Surgery Reimbursement Update, December 13, 2005

The Centers for Medicare & Medicaid Services (CMS) has approved Boston Scientific Corp.'s application for a new series of Healthcare Common Procedure Coding System (HCPCS) device reimbursement codes in the ambulatory surgery center setting, according to Aging & Elder Health Week with information from NewsRx.com and NewsRx.net.

These new HCPCS codes apply to the company's Precision rechargeable neurostimulators, which are used to treat chronic intractable pain.

"We are delighted that CMS recognizes the value that rechargeable neurostimulators such as the Precision SCS System offer to Medicare patients," said Jeff Greiner, head of Boston Scientific's Neuromodulation Group. "This favorable decision will help ensure that Medicare patients with chronic intractable pain will have access to state-of-the-art medical technology in all settings."

The new codes become effective for services beginning January 1.

Most Popular